AstraZeneca cancels £450m vaccine plant in UK

AstraZeneca scraps plan to expand vaccine plant in the UK in blow to government
Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in northwest England.
AstraZeneca ditches plan to build new UK vaccine plant
AstraZeneca is pulling out of its plans to build a £450mn UK vaccine manufacturing plant after months of wrangling with British officials about state investment for the Merseyside project, in a major blow to Prime Minister Sir Keir Starmer’s government.
AstraZeneca cancels £450m vaccine plant in UK after Government 'own goal' in blow to Rachel Reeves growth plan
AstraZeneca cancels £450m vaccine plant in UK after Government 'own goal' in blow to Rachel Reeves growth plan - The pharmaceutical giant claimed the Labour Government failed to match Tory predecessor
AstraZeneca abandons £450m vaccine factory in blow to Reeves
AstraZeneca has abandoned a £450m investment in a major UK vaccine plant just days after Rachel Reeves vowed to “kick-start economic growth”.
AstraZeneca scraps £450m vaccine plant after Labour funding cut
AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a cut in funding from government.
AstraZeneca scraps £450M expansion at UK vaccine plant, citing reduced government contribution
AstraZeneca’s manufacturing will-they-won’t-they within its home country has swung back firmly toward the ‘they won’t’ camp after the British pharma confirmed that it’s ditching a major venture at | AstraZeneca is pulling the plug on a 450 million pound sterling investment at its vaccine production site in England due in large part to the reduction of a planned financial contribution from the U.
AstraZeneca Scraps $560M Vaccine Plant Plans in England
AstraZeneca has cancelled a £450 million vaccine facility investment in England, citing reduced financial support from the new Labour government. The move undermines UK Treasury's economic growth plans and highlights tensions with the pharmaceutical sector.
Ministers may find it hard to defend AstraZeneca vaccine plant blow given economic climate of contagious scepticism
In substance and timing, AstraZeneca's decision to cancel a planned expansion of its flu vaccine facility at Speke is a blow to the government's recent zeal for growth. Instead of injecting £450m into the plant on Merseyside,
AstraZeneca ditches plan to build $558 mln UK vaccine plant
AstraZeneca is no longer pursuing plans for a 450 million pound ($558.32 million) vaccine manufacturing plant in Speke, Liverpool, a company spokesperson said on Friday.
AstraZeneca Scraps Plan To Expand Vaccine Plant In UK In Blow To Government
In a blow to Treasury chief Rachel Reeves at the end of a week when she trumpeted the government's plans to bolster British economic growth and make the country more attractive to international investors,
Rachel Reeves dealt blow with AstraZeneca axing £450m vaccine plant plans
AstraZeneca has axed plans to build a £450million vaccine manufacturing plant because of a lack of Government support in the latest blow to Rachel Reeves. The Labour government last summer tried to reduce the amount of state support provided to the Liverpool project from about £90million to £40million,
AstraZeneca Calls Off Vaccine Hub Investment Over UK Funding
AstraZeneca Plc abandoned plans to invest £450 million ($558 million) in a UK vaccine manufacturing plant, following protracted wrangling with the new Labour government over the level of state funding ...
‘I was desperate for the AstraZeneca vaccine to succeed. Then I became alarmed by what I saw’
When Oxford University developed the AstraZeneca vaccine, Dr Sue Pavord, a consultant haematologist, was so eager for it to ...
FierceBiotech1d
AstraZeneca antibody protects macaques from severe bird flu, suggesting prophylactic potential in case of outbreak
All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...